From basics to clinics: New opportunities for metformin in tumor metabolic intervention and treatment
Open Access
- 1 September 2025
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118507
Abstract
No abstract availableKeywords
Funding Information
- Higher Education Discipline Innovation Project (D20036)
- Key Scientific Research Project of Colleges and Universities in Henan Province (25A320018)
- Key Scientific Research Project of Colleges and Universities in Henan Province (25A180011)
- Hainan Association for Science and Technology
This publication has 138 references indexed in Scilit:
- The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwideInternational Journal of Cancer, 2024
- Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR‐378a‐3p/VEGFA/RGC‐32 AxisCancer Medicine, 2024
- Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cellsArchiv der Pharmazie, 2024
- Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast CancerAdvanced Healthcare Materials, 2024
- Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapyJournal of Cellular Physiology, 2024
- Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathwaysCell Biochemistry and Function, 2024
- Metformin usage and the risk of colorectal cancer: a national cohort studyInternational Journal of Colorectal Disease, 2020
- A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG‐asparaginase, and doxorubicinPediatric Blood & Cancer, 2018
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signalingIUBMB Life, 2016
- Metformin influences progression in diabetic glioblastoma patientsStrahlentherapie und Onkologie, 2015